Effect of Bupivacaine hydrogel on post-operation pain in impacted wisdom tooth

Evaluation the effect of Carbomer based Bupivacaine hydrogel on post-operation pain in impacted mandibular wisdom tooth

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221201056682N1

Enrollment

Registered

2023-07-17

Start date

2023-09-10

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post operation pain.

Interventions

Intervention 1: Intervention group: Carbomer-based hydrogel was prepared by the pharmaceutical department of Shahid Beheshti Faculty of Pharmacy with a ratio of 7.5 mg/cc of the active ingredient in a

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: patients with impacted mesioangular mandibular wisdom teeth class B and C of Pell and Gregory classification Growth of at least 1/2 to 2/3 of the wisdom tooth root

Exclusion criteria

Exclusion criteria: Patients with other than mesioangular depression and other Pell and Gregory classes Continuous use of opioid and non-steroidal pain medications The presence of any systemic disease Allergy to bupivacaine or carbomer

Design outcomes

Primary

Measure	Time frame
Patient's post operation pain scale. Timepoint: measure pain in 2, 6, 12, 24, 48 and 72 hours after surgery. Method of measurement: Visual Analogue Scale.	—

Secondary

Measure	Time frame
Painkiller usage. Timepoint: 2, 6, 12, 24, 48 and 72 hours after surgery. Method of measurement: self statement.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactErfan Khorasani

Qazvin University of Medical Sciences

e.khorasani@qums.ac.ir009833353061

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026